This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Epilepsy or Bipolar Disorder
and you are
between 21 and 47
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To demonstrate the relative bioavailability of Divalproex Sodium 500 mg delayed release tablets under fed conditions.

Provided treatments

  • Drug: Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)
  • Drug: Depakote 500 mg DR Tablets (Abbott Laboratories, USA)
Tris trial is registered with FDA with number: NCT00913848. The sponsor of the trial is Sandoz and it is looking for 30 volunteers for the current phase.
Official trial title:
A Single-Dose Comparative Bioavailability Study of Two Formulations of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions